ZHEJIANG SHAPUAISI PHARMAC

Investors Eye Zhejiang Shapuaisi: Flat Trading, Strong Ophthalmic Upside

Explore Zhejiang Shapuaisi’s steady 2026 trading outlook—eye‑care specialist trading at CNY 5.80, poised for growth after new regulatory approvals and Southeast‑Asia expansion.

ZHEJIANG SHAPUAISI PHARMAC
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

21/10/2026, 11:46

3 minutes to read

Zhejiang Shapuaisi Pharmaceutical: Stable Stock, Growing Ophthalmic Opportunities

Stable yet poised, Zhejiang Shapuaisi Pharmaceutical (603168.SS) trades near its 200‑day average, ready to ride rising demand for innovative ophthalmic drugs and upcoming regulatory approvals.

ZHEJIANG SHAPUAISI PHARMAC
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

21/10/2026, 03:55

3 minutes to read